ID: ALA3120704

Max Phase: Preclinical

Molecular Formula: C21H32

Molecular Weight: 284.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=CCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC

Standard InChI:  InChI=1S/C21H32/c1-3-5-7-9-11-13-15-17-19-21-20-18-16-14-12-10-8-6-4-2/h3,6,8,11-14,17-20H,1,4-5,7,9-10,15-16,21H2,2H3/b8-6-,13-11-,14-12-,19-17-,20-18-

Standard InChI Key:  FDYJPTFUAQLZOU-DYXXURTGSA-N

Associated Targets(non-human)

LOX1.4 Seed linoleate 9S-lipoxygenase (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 284.49Molecular Weight (Monoisotopic): 284.2504AlogP: 7.09#Rotatable Bonds: 13
Polar Surface Area: 0.00Molecular Species: HBA: 0HBD: 0
#RO5 Violations: 1HBA (Lipinski): 0HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 7.69CX LogD: 7.69
Aromatic Rings: 0Heavy Atoms: 21QED Weighted: 0.25Np Likeness Score: 1.16

References

1. Kurihara H, Kagawa Y, Konno R, Kim SM, Takahashi K..  (2014)  Lipoxygenase inhibitors derived from marine macroalgae.,  24  (5): [PMID:24495846] [10.1016/j.bmcl.2014.01.046]

Source